Evidence map›Paper›PMID 19447883›Full record

ArticleThe Journal of biological chemistry2009

Intestinal anion exchanger down-regulated in adenoma (DRA) is inhibited by intracellular calcium.

Georg Lamprecht, Chih-Jen Hsieh, Simone Lissner, Lilia Nold, Andreas Heil, Veronika Gaco, Julia Schäfer, Jerrold R Turner, Michael Gregor

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. SLC26 Anion Transporters.Handbook of experimental pharmacology · 2024
    Review
  4. SLC26A3 (DRA) is stimulated in a synergistic, intracellular CaAmerican journal of physiology. Cell physiology · 2023
    Article
  5. Advances in CaExperimental and therapeutic medicine · 2020
    Review
  6. Article
  7. Keratin 8 knockdown leads to loss of the chloride transporter DRA in the colon.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  8. Article
  9. Article
  10. Functional regulation of the SLC26-family protein prestin by calcium/calmodulin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  11. Translating molecular physiology of intestinal transport into pharmacologic treatment of diarrhea: stimulation of Na+ absorption.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2014
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Georg Lamprecht1st Medical Department, University of Tübingen, 72076 Tübingen, Germany. hans-georg.lamprecht@uni-tuebingen.de
Chih-Jen Hsieh
Simone Lissner
Lilia Nold
Andreas Heil
Veronika Gaco
Julia Schäfer
Jerrold R Turner
Michael Gregor
University of Tübingen · DEUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Na/H exchanger 3 (NHE3) and the Cl/HCO(3) exchanger down-regulated in adenoma (DRA) together facilitate intestinal electroneutral NaCl absorption. Elevated Ca(2+)(i) inhibits NHE3 through mechanisms involving the PDZ domain proteins NHE3 kinase A regulatory protein (E3KARP) or PDZ kidney 1 (PDZK1). DRA also possesses a PDZ-binding motif, but the roles of interactions with E3KARP or PDZK1 and Ca(2+)(i) in DRA regulation are unknown. Wild type DRA and a mutant lacking the PDZ interaction motif (DRA-ETKFminus) were expressed constitutively in human embryonic kidney (HEK) and inducibly in Caco-2/BBE cells. DRA-mediated Cl/HCO(3) exchange was measured as intracellular pH changes. Ca(2+)(i) was assessed fluorometrically. DRA was induced 8-16-fold and was delivered to the apical surface of polarized Caco-2 cells. Putative anion transporter 1 and cystic fibrosis transmembrane regulator did not contribute to Cl/HCO(3) exchange in transfected Caco-2 cells. The calcium ionophore 4Br-A23187 inhibited DRA and DRA-ETKFminus in HEK cells, but only full-length DRA was inhibited in Caco-2 cells. In contrast, 100 microm UTP, which increased Ca(2+)(i), inhibited full-length DRA but not DRA-ETKFminus in Caco-2 and HEK cells. In HEK cells, which express little PDZK1, additional transfection of PDZK1 was required for UTP to inhibit DRA. As HEK cells do not express cystic fibrosis transmembrane regulator or NHE3, the data indicate that Ca(2+)(i)-dependent DRA inhibition is not because of modulation of other transport activities. In polarized epithelium, this inhibition requires interaction of DRA with PDZK1. Together with data from PDZK1(-/-) mice, these data underscore the prominent role of PDZK1 in Ca(2+)(i)-mediated inhibition of colonic NaCl absorption.

Indexed as

AntiportersBinding SitesCaco-2 CellsCalcimycinCalciumCell LineChloride-Bicarbonate AntiportersCystic Fibrosis Transmembrane Conductance RegulatorGene ExpressionGreen Fluorescent ProteinsHumansHydrogen-Ion ConcentrationImmunoblottingIntestinal MucosaIntracellular SpaceIonophores4-bromo-A-23187AntiportersCalcimycinCalciumCFTR protein, humanChloride-Bicarbonate AntiportersCystic Fibrosis Transmembrane Conductance RegulatorGreen Fluorescent ProteinsIonophoresMembrane ProteinsPDZK1IP1 protein, humanPhosphoproteinsRecombinant Fusion ProteinsSLC26A3 protein, humanSLC9A3 protein, humanSlc9a3 protein, mouseSodium-Hydrogen Exchanger 3sodium-hydrogen exchanger regulatory factorSodium-Hydrogen ExchangersSulfate TransportersUridine Triphosphate

Identifiers

PMID19447883
PMCPMC2740598
OpenAlexW2026050056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.